Transthyretin Amyloidosis with Polyneuropathy
📧 Sign up to get email alerts when something new happens for Transthyretin Amyloidosis with Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-10-17FDA Approved: VYNDAMAX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for VYNDAMAX (tafamidis) from Pfizer Laboratories Div Pfizer Inc, typically to support labeling …